Absci

Absci is a clinical-stage biopharmaceutical company headquartered in Vancouver, Washington that advances therapeutics designed with...

Startup

Facts

HQ: Vancouver, Wash.
Sectors: Biotechnology, Artificial Intelligence, Drug discovery
Stage: Clinical-stage

Signed a material agreement Jun 24, 2026 SEC Form 8-K
Leadership or executive-pay change Mar 6, 2026 SEC Form 8-K
Signed a material agreement Mar 6, 2026 SEC Form 8-K
Signed a material agreement Nov 4, 2025 SEC Form 8-K
Signed a material agreement Jul 25, 2025 SEC Form 8-K
Leadership or executive-pay change Jul 8, 2025 SEC Form 8-K
Leadership or executive-pay change Apr 28, 2025 SEC Form 8-K
Signed a material agreement Feb 28, 2024 SEC Form 8-K
Leadership or executive-pay change Dec 7, 2023 SEC Form 8-K
Leadership or executive-pay change Aug 17, 2023 SEC Form 8-K
Leadership or executive-pay change Aug 14, 2023 SEC Form 8-K
Signed a material agreement Jun 16, 2023 SEC Form 8-K
Leadership or executive-pay change Jun 6, 2023 SEC Form 8-K
Leadership or executive-pay change Nov 2, 2022 SEC Form 8-K
Leadership or executive-pay change Oct 4, 2022 SEC Form 8-K
Leadership or executive-pay change Sep 20, 2022 SEC Form 8-K
Leadership or executive-pay change Jul 14, 2022 SEC Form 8-K
Leadership or executive-pay change Mar 21, 2022 SEC Form 8-K
Leadership or executive-pay change Jan 10, 2022 SEC Form 8-K
Leadership or executive-pay change Aug 24, 2021 SEC Form 8-K

Online